 |
Immunocore
Last updated: May 07, 2024
Founder Bent Jakobsen
UK | Funding: $1.2B (+)
Website: http://immunocore.com/
Immunocore is a privately owned, clinical-stage, UK-based biotechnology company, focused on the discovery and development of novel T cell receptor-based drugs to treat diseases with a high unmet need, including cancer and viral disease.
Website: http://immunocore.com/
Immunocore is a privately owned, clinical-stage, UK-based biotechnology company, focused on the discovery and development of novel T cell receptor-based drugs to treat diseases with a high unmet need, including cancer and viral disease.
